Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study

Aletti, 2006, Aggressive surgical effort and improved survival in advanced-stage ovarian cancer, Obstet. Gynecol., 107, 77, 10.1097/01.AOG.0000192407.04428.bb Wallace, 2017, Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible, Gynecol. Oncol., 145, 21, 10.1016/j.ygyno.2017.01.029 Chi, 2006, What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?, Gynecol. Oncol., 103, 559, 10.1016/j.ygyno.2006.03.051 Cai, 2007, The role of bowel surgery with cytoreduction for epithelial ovarian cancer, Clin. Oncol., 19, 757, 10.1016/j.clon.2007.06.015 Tozzi, 2019, Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer, J. Gynecol. Oncol., 30 Vergote, I. et al. Neoadjuvant Chemotherapy or Debulking Surgery in Stage Supplementary Material 4 5 6. Richardson, 2006, Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer, Gynecol. Oncol., 103, 667, 10.1016/j.ygyno.2006.05.003 Mourton, 2005, Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer, Gynecologic Oncology, 99, 608, 10.1016/j.ygyno.2005.07.112 Nelson, 2019, Guidelines for perioperative care in gynecologic/oncology: enhanced recovery after surgery (ERAS) society recommendations-2019 update, Int. J. Gynecol. Cancer, 29, 651, 10.1136/ijgc-2019-000356 Chen, 2016, Comparing mechanical bowel preparation with both oral and systemic antibiotics versus mechanical bowel preparation and systemic antibiotics alone for the prevention of surgical site infection after elective colorectal surgery: a meta-analysis of randomize, Dis. Colon Rectum, 59, 70, 10.1097/DCR.0000000000000524 Yang, 2017, Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: a meta-analysis of peri-operative outcome, PLoS One, 12 Onda, 2016, Eur. J. Cancer, 64, 22, 10.1016/j.ejca.2016.05.017 Fagotti, 2016, Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome, Eur. J. Cancer, 59, 22, 10.1016/j.ejca.2016.01.017 Vergote, 2010, Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer, N. Engl. J. Med., 363, 943, 10.1056/NEJMoa0908806 Kehoe, 2015, Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial, Lancet, 386, 249, 10.1016/S0140-6736(14)62223-6 Heinze, 2017, Five myths about variable selection, Transpl. Int., 30, 6, 10.1111/tri.12895 Lee, 2018, What is the proper way to apply the multiple comparison test?, Korean J. Anesthesiol., 71, 353, 10.4097/kja.d.18.00242 Taylor, 2017, The DISINFECT initiative: decreasing the incidence of surgical INFECTions in gynecologic oncology, Ann. Surg. Oncol., 24, 362, 10.1245/s10434-016-5517-4 Matsuo, 2012, Significance of perioperative infection in survival of patients with ovarian cancer, Int. J. Gynecol. Cancer, 22, 245, 10.1097/IGC.0b013e31823bd6db Fournier, 2018, Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis, Eur. J. Surg. Oncol., 44, 750, 10.1016/j.ejso.2018.01.005 Mahdi, 2014, Surgical site infection in women undergoing surgery for gynecologic cancer, Int. J. Gynecol. Cancer, 24, 779, 10.1097/IGC.0000000000000126 Tran, 2015, Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survival, Gynecologic Oncology, 136, 278, 10.1016/j.ygyno.2014.12.007 O'Donnell, R. L. et al. Impact of Surgical Site Infection (SSI) Following Gynaecological Cancer Surgery in the UK: a Trainee-Led Multicentre audit and Service Evaluation. doi:https://doi.org/10.1136/bmjopen-2018-024853. Lippitt, 2017, Outcomes associated with a five-point surgical site infection prevention bundle in women undergoing surgery for ovarian cancer, Obstetrics and Gynecology, 130, 756, 10.1097/AOG.0000000000002213 Shepard, 2013, Financial impact of surgical site infections on hospitals: the hospital management perspective, JAMA Surg., 148, 907, 10.1001/jamasurg.2013.2246 Perencevich, 2003, Health and economic impact of surgical site infections diagnosed after hospital discharge, Emerg. Infect. Dis., 9, 196, 10.3201/eid0902.020232 Lawson, 2013, Risk factors for superficial vs deep/organ-space surgical site infections: implications for quality improvement initiatives, JAMA Surg., 148, 1, 10.1001/jamasurg.2013.2925 Caroff, 2019, Association of open approach vs laparoscopic approach with risk of surgical site infection after colon surgery, JAMA Netw. Open, 2 Ishikawa, 2014, Incisional surgical site infection after elective open surgery for colorectal cancer, Int. J. Surg. Oncol., 2014 Aimaq, 2011, Surgical site infection rates in laparoscopic versus open colorectal surgery, Am. Surg., 77, 1290, 10.1177/000313481107701003 Malone, 2002, Surgical site infections: reanalysis of risk factors, J. Surg. Res., 103, 89, 10.1006/jsre.2001.6343 Fleetwood, 2016, Primary anastomosis versus ostomy after colon resection during debulking of ovarian carcinomatosis: a NSQIP analysis, Am. Surg., 82, 302, 10.1177/000313481608200413 Tseng, 2016, Diverting ileostomy during primary debulking surgery for ovarian cancer: associated factors and postoperative outcomes ☆, Gynecol. Oncol., 142, 217, 10.1016/j.ygyno.2016.05.035 Wong, 2005, A defunctioning ileostomy does not prevent clinical anastomotic leak after a low anterior resection: a prospective, comparative study, Dis. Colon Rectum, 48, 2076, 10.1007/s10350-005-0146-1 Nelson, 2016, Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: enhanced recovery after surgery (ERAS®) society recommendations - part i, Gynecol. Oncol., 140, 313, 10.1016/j.ygyno.2015.11.015 Grant, 2017, Impact of enhanced recovery after surgery and fast track surgery pathways on healthcare-associated infections: results from a systematic review and meta-analysis, Ann. Surg., 265, 68, 10.1097/SLA.0000000000001703 Johnson, 2016, Using bundled interventions to reduce surgical site infection after major gynecologic cancer surgery, Obstetrics and Gynecology, 127, 1135, 10.1097/AOG.0000000000001449 Lachiewicz, M. P., Moulton, L. J. & Jaiyeoba, O. Pelvic surgical site infections in gynecologic surgery. Infect. Dis. Obstet. Gynecol. 2015, 614950 (2015). Bratzler, 2013, Clinical practice guidelines for antimicrobial prophylaxis in surgery, Surg. Infect., 14, 73, 10.1089/sur.2013.9999 Mcdonald, 1998, Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review, Aust. N. Z. J. Surg., 68, 388, 10.1111/j.1445-2197.1998.tb04785.x Song, 1998, Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials, Br. J. Surg., 85, 1232, 10.1046/j.1365-2168.1998.00883.x Knisely, 2020 Melamed, 2016, Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States, Gynecol. Oncol., 143, 236, 10.1016/j.ygyno.2016.09.002 Chen, 2016, Dis. Colon Rectum, 59, 70, 10.1097/DCR.0000000000000524